Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Lane

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
The American Journal of Clinical Nutrition|February 1, 2022
Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patientsSreedhar Subramanian, Jonathan M Rhodes, Joseph M Taylor, et al.
Brain, Behavior, and Immunity|November 4, 2023
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB studyInti Qurashi, Imran B Chaudhry, Ameer B Khoso, et al.
Leukemia Research|April 27, 2013
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemiaSebastian Francis, Claire Lucas, Steven Lane, et al.
Plos One|October 29, 2020
Identifying critically ill children at high risk of acute kidney injury and renal replacement therapyRachel J McGalliard, Stephen J McWilliam, Samuel Maguire, et al.
The Journal of Clinical Investigation|October 21, 2009
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cellsZhihui Zhong, Hristelina Ilieva, Lee Hallagan, et al.
Blood|August 5, 2024
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND studyDavid T Yeung, Naranie Shanmuganathan, John Reynolds, et al.
Blood Advances|June 25, 2020
Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malariaChristopher A Moxon, Yasir Alhamdi, Janet Storm, et al.
Journal of Molecular Biology|July 5, 2011
Whole-molecule antibody engineering: generation of a high-affinity anti-IL-6 antibody with extended pharmacokineticsDonna K Finch, Matthew A Sleeman, Jacques Moisan, et al.
Internal Medicine Journal|December 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesAshlea Campbell, Benjamin Teh, Stephen Mulligan, et al.
Rheumatology (Oxford, England)|March 10, 2021
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort StudyEve M D Smith, Sajida Rasul, Coziana Ciurtin, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
The American Journal of Clinical Nutrition|February 1, 2022
Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patientsSreedhar Subramanian, Jonathan M Rhodes, Joseph M Taylor, et al.
Brain, Behavior, and Immunity|November 4, 2023
A randomised double-blind placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at risk Mental States: The NAYAB studyInti Qurashi, Imran B Chaudhry, Ameer B Khoso, et al.
Leukemia Research|April 27, 2013
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemiaSebastian Francis, Claire Lucas, Steven Lane, et al.
Plos One|October 29, 2020
Identifying critically ill children at high risk of acute kidney injury and renal replacement therapyRachel J McGalliard, Stephen J McWilliam, Samuel Maguire, et al.
The Journal of Clinical Investigation|October 21, 2009
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cellsZhihui Zhong, Hristelina Ilieva, Lee Hallagan, et al.
Blood|August 5, 2024
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND studyDavid T Yeung, Naranie Shanmuganathan, John Reynolds, et al.
Blood Advances|June 25, 2020
Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malariaChristopher A Moxon, Yasir Alhamdi, Janet Storm, et al.
Journal of Molecular Biology|July 5, 2011
Whole-molecule antibody engineering: generation of a high-affinity anti-IL-6 antibody with extended pharmacokineticsDonna K Finch, Matthew A Sleeman, Jacques Moisan, et al.
Internal Medicine Journal|December 26, 2023
Australia and New Zealand consensus position statement: use of COVID-19 therapeutics in patients with haematological malignanciesAshlea Campbell, Benjamin Teh, Stephen Mulligan, et al.
Rheumatology (Oxford, England)|March 10, 2021
Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort StudyEve M D Smith, Sajida Rasul, Coziana Ciurtin, et al.
Pageof 15